| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 08/01/2000 | US6096724 O(6)-alkylguanine-dna alkyltransferase (atase) enzyme inhibitors |
| 08/01/2000 | US6096499 Mammalian DNA primase screen and activity modulating agents |
| 08/01/2000 | CA2066640C Heterocyclic compounds |
| 08/01/2000 | CA2014771C 5,11-dihydro-6h-dipyrido[3,2-b:2'3'-e][1,4]diazepin-6-ones and their use in the prevention or treatment of aids |
| 07/28/2000 | CA2293008A1 Premixed alatrofloxacin injectable compositions |
| 07/27/2000 | WO2000043398A2 Tricyclic benzodiazepines as vasopressin receptor antagonists |
| 07/27/2000 | WO2000043392A2 Use of imidazo[1,5-a]-pyrido[3,2-e]-pyrazinones as medicaments |
| 07/27/2000 | WO2000043383A1 Piperidinylquinolines as protein tyrosine kinase inhibitors |
| 07/27/2000 | WO2000043375A2 Substituted aryl heterocyclic compounds |
| 07/27/2000 | WO2000023433A8 Substituted benzopyran analogs for the treatment of inflammation |
| 07/27/2000 | WO2000008202A9 3-methylidenyl-2-indolinone modulators of protein kinase |
| 07/27/2000 | WO1999066944A9 Methods for identifying novel multimeric agents that modulate receptors |
| 07/27/2000 | WO1999064033A9 Phosphodiesterase-v modulator drugs and their uses |
| 07/27/2000 | WO1999063994A9 MULTIBINDING INHIBITORS OF HMG-CoA REDUCTASE |
| 07/27/2000 | DE19902082A1 New and known imidazo(1,5-a)pyrido(3,2-e)pyrazinone derivatives, useful as phosphodiesterase 5 inhibitors for treating erectile dysfunction |
| 07/27/2000 | DE19900063A1 Naphthalin- und Perylenhydrazamimide - eine neue Klasse von Farbstoffen Naphthalene and Perylenhydrazamimide - a new class of dyes |
| 07/26/2000 | EP1022274A1 Oxazolidinedione and Thiazolidinedione derivatves, their preparation and their use |
| 07/26/2000 | EP1022272A1 Substituted fused heterocyclic compounds |
| 07/26/2000 | EP1022026A2 Pharmaceutical compositions for treating nitrate-induced tolerance |
| 07/26/2000 | EP1021448A1 TRICYCLIC COMPOUNDS HAVING ACTIVITY AS Ras-FPT INHIBITORS |
| 07/26/2000 | EP1021415A1 Tricyclic aminoalkylcarboxamides; novel dopamine d 3? receptor subtype specific ligands |
| 07/26/2000 | EP1021413A1 The preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 07/26/2000 | EP0797577B1 Bicyclic nonane and decane compounds having dopamine receptor affinity |
| 07/26/2000 | EP0641781B1 4-amino(alkyl)cyclohexane-1-carboxamide compound and use thereof |
| 07/26/2000 | EP0556393B1 Fused pyrazine derivative |
| 07/26/2000 | EP0556319B1 Sampangine derivatives useful as antifungal agents |
| 07/26/2000 | CN1261350A Tetrahydroisoquinoline derivatives as modulators of dopamine D3 receptors |
| 07/26/2000 | CN1261276A Protease inhibitors |
| 07/25/2000 | US6093821 Process for preparing steroid receptor modulator compounds |
| 07/25/2000 | US6093739 Therapeutic macrocycle compounds useful in photodynamic therapy that are based on the chlorin ring system |
| 07/25/2000 | US6093734 Pyridyl methyl sulfinyl benzimidazole type proton pump inhibitor drugs having a hydrolyzable sulfinyl or arylsulfonyl group attached to the benzimidazole nitrogen; gastrointestinal disorders |
| 07/25/2000 | US6093732 4-hydroxyquinoline-3-carboxamides and hydrazides as antiviral agents |
| 07/25/2000 | US6093728 Methods of modulating serine/threonine protein kinase function with azabenzimidazole-based compounds |
| 07/25/2000 | US6093727 A selective agonists for human alpha 2 receptors for treating disorders as hypertension, pain, glaucoma, alcohol and drug withdrawal, ischemia, rheumatoid arthritis, migraine, cognitive deficiency, spasticity, diarrhea, nasal congestion |
| 07/25/2000 | US6093724 Muscarinic agonists and antagonists |
| 07/25/2000 | US6093723 An immunomodulator for treating and preventing immune disorders, including autoimmune disease, inflammatory disease, organ transplant rejection and other disorders associated with il-2 mediated immune response |
| 07/25/2000 | US6093717 Imidazopyridine thrombin inhibitors |
| 07/20/2000 | WO2000042071A2 Compounds and methods to inhibit or augment an inflammatory response |
| 07/20/2000 | WO2000042048A1 A reagent system and method for increasing the luminescence of lanthanide(iii) macrocyclic complexes |
| 07/20/2000 | WO2000042044A1 Novel aralkyl amines of spirofuropyridines useful in therapy |
| 07/20/2000 | WO2000042040A1 Tricyclic inhibitors of poly(adp-ribose) polymerases |
| 07/20/2000 | WO2000041697A1 Utilisation of 2-substituted 1,2-benzisothiazole derivatives and 3-substituted tetrahydropyridopyrimidinone derivatives for the prophylaxis and therapy of cerebral ischaemia |
| 07/20/2000 | WO2000029406A3 Novel isoxazoline fibrinogen receptor antagonists |
| 07/20/2000 | WO1999064048A9 Inhibitors of hiv reverse transcriptase |
| 07/20/2000 | DE19901846A1 New aryl-substituted aza-heterocyclic compounds, useful as pre- or post-emergence, total or selective herbicides, show defoliant, dessicant and especially weed-killing activity |
| 07/20/2000 | CA2697598A1 Compounds and methods to inhibit or augment an inflammatory response |
| 07/20/2000 | CA2360054A1 Reagent system and method for increasing the luminescence of lanthanide (iii) macrocyclic complexes |
| 07/20/2000 | CA2359990A1 Novel aralkyl amines of spirofuropyridines useful in therapy |
| 07/20/2000 | CA2359390A1 Utilisation of 2-substituted 1,2-benzisothiazole derivatives and 3-substituted tetrahydropyridopyrimidinone derivatives for the prophylaxis and therapy of cerebral ischaemia |
| 07/20/2000 | CA2296224A1 Use of imidazo(1,5-a)pyrido(3,2-e)pyrazinones |
| 07/19/2000 | EP1020467A1 N-acylamino acid amide compounds and intermediates for preparation thereof |
| 07/19/2000 | EP1020451A1 Novel anilide compounds and drugs containing the same |
| 07/19/2000 | EP1020446A1 Naphthalimidobenzamide derivatives |
| 07/19/2000 | EP1020445A1 Fused pyridine derivatives |
| 07/19/2000 | EP1020427A1 Agent for potentiating nerve growth factor activity containing 1,2-ethanediol derivative or salt thereof |
| 07/19/2000 | EP1020190A2 Treatment of BPH with cGMP elevators |
| 07/19/2000 | EP1019425A1 Modified benzimidazole nucleosides as antiviral agents |
| 07/19/2000 | EP1019409A1 Poly(adp-ribose) polymerase ("parp") inhibitors, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage |
| 07/19/2000 | EP1019402A1 Polymorphic forms of a growth hormone secretagogue |
| 07/19/2000 | EP1019401A1 Complex comprising a rare-earth metal ion and a complexing moiety |
| 07/19/2000 | EP1019383A2 Process for the aminocarbonylation of benzazepines and benzodiazepines |
| 07/19/2000 | EP1019382A1 Compounds and compositions for treating diseases associated with serine protease, particularly tryptase, activity |
| 07/19/2000 | EP1019380A2 Tricyclic 3-oxo-propanenitrile compounds |
| 07/19/2000 | EP1019373A1 Novel human nk 3? receptor-selective antagonist compounds, method for obtaining them and pharmaceutical compositions containing them |
| 07/19/2000 | EP1019360A1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS |
| 07/19/2000 | EP1019095A1 Method for the preparation of facial metal tricarbonyl compounds and their use in the labelling of biologically active substrates |
| 07/19/2000 | EP1019075A1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS |
| 07/19/2000 | EP1019058A1 Pharmaceutical suspension comprising nevirapine hemihydrate |
| 07/19/2000 | EP1019046A1 Protease inhibitors |
| 07/19/2000 | EP0760819B1 Tricyclic dicarbonyl derivatives |
| 07/19/2000 | CN1260796A Alkaloid halide salts of swainsonine and methods of use |
| 07/18/2000 | US6090945 Tetrahydro-beta-carbolines |
| 07/18/2000 | US6090944 Alkanoic acid derivatives as αv integrin receptor antagonists |
| 07/18/2000 | US6090820 Spirocyclic and bicyclic diazinyl and carbazinyl oxazolidinones |
| 07/18/2000 | US6090817 Respiratory system disorders; phosphodiesterse inhibitor |
| 07/18/2000 | US6090807 Use of heterocyclic compounds |
| 07/18/2000 | US6090804 Psychological disorders; schizophrenia therapy |
| 07/18/2000 | US6090803 Tricyclic vasopressin agonists |
| 07/13/2000 | WO2000040657A1 Naphthalenehydrazamimides and perylenehydrazamimides |
| 07/13/2000 | WO2000040584A2 Process for preparing n6-substituted deaza-adenosine derivatives |
| 07/13/2000 | WO2000040583A2 Imidazo[4,5-c]-pyridine-4-on-derivatives |
| 07/13/2000 | WO2000040581A1 3,4-dihydro-2h-benzo[1,4]oxazine derivatives |
| 07/13/2000 | WO2000040560A1 Aminoalcohol derivatives and their use as beta 3 adrenergic agonists |
| 07/13/2000 | WO2000040554A1 Arylpiperazinyl-cyclohexyl indole derivatives for the treatment of depression |
| 07/13/2000 | WO2000040539A1 Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases |
| 07/13/2000 | WO2000040244A1 Use of phanquinone for the treatment or prevention of memory impairment |
| 07/13/2000 | WO2000040228A2 Formulations comprising imiquimod or other immune response modifiers for treating mucosal conditions |
| 07/13/2000 | WO2000040226A2 Method of treating sexual disturbances |
| 07/13/2000 | WO2000024741A3 Dihydropyridine compounds and their use as potassium channel openers |
| 07/13/2000 | WO2000021927A3 Pyrrole-2,5-diones as gsk-3 inhibitors |
| 07/13/2000 | WO2000008020A3 Tricyclic carboxamides |
| 07/13/2000 | DE19900576A1 New substituted allyl-, glycidyl- or hydroxypropyl-benzene derivatives, used as intermediates for drugs, especially central nervous system drugs, particularly the antidepressants paroxetine and femoxetine |
| 07/13/2000 | DE19900544A1 Verwendung von Verbindungen der Formel I zur Prophylaxe und Therapie der zerebralen Ischämie Use of compounds of formula I for the prophylaxis and therapy of cerebral ischemia |
| 07/13/2000 | DE19900471A1 Imidazo[4,5c]-pyridin-4-on-derivate Imidazo [4,5c] pyridin-4-one derivatives |
| 07/13/2000 | CA2358962A1 Process for preparing n6-substituted deaza-adenosine derivatives |
| 07/13/2000 | CA2357771A1 Imidazo[4,5-c]-pyridine-4-one derivatives |
| 07/13/2000 | CA2356053A1 Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases |
| 07/13/2000 | CA2355342A1 Arylpiperazinyl-cyclohexyl indole derivatives for the treatment of depression |
| 07/13/2000 | CA2350946A1 Method of treating sexual disturbances |
| 07/12/2000 | EP1018512A1 Novel basic derivatives of benz(e)isoindol-1-ones and pyrrolo(3,4-c)quinolin-1-ones with 5-HT3-antagonistic activity, their preparation and their therapeutic use |